Here is a list of different pages dedicated to certain types of stocks. Each page will also have more stocks listed on that page. We put this together to make it easy for you to easily sort through different type of stocks. Click on the linked text below to access the page. If you believe certain stocks should be added to the list please comment on the page. The more everyone can pitch in and help out the more useful information we will all have.
Marijuana Stocks – This has a list of marijuana stocks in both the OTC and those trading in countries like Canada. We also put a few of the stocks on a watch-list when we believe they could see some buying momentum. This list will include stocks that are in any way or form related to the marijuana and Cannabis industry. Make sure you scroll through the entire page. It can be a little overwhelming at first which is why we recommend bookmarking our site so you can come back another time.
Bitcoin Stocks – Crypto Currency has taken the world by storm. On the one side you have people who believe it will be a huge part of the future and others that believe it is just a fad. We put a list together of a few of the more popular crypto-currencies stocks. Please feel free to comment with any new stocks that you feel should be added.
Oil Stocks – Oil is an industry that has been around one of the longest in the stock market. The sector has had its up and downs but has always seem to recover and grow. On this page you will find a list of oil stocks and oil penny stocks. Please feel free to comment on the page with stocks you feel should be added.
Gold Stocks – Gold is another industry that has changed the world over the last several thousands of years. Today most of the worlds gold is traded and bought by India and by China but there is still huge money in gold. This list will include any companies that are related to Gold including Gold mining companies.
Sub Penny Stocks – This is a list of stocks we put together that are under .01 and under 1 billion authorized shares. This list is changing all the times so it is important to try to verify authorized shares with a transfer agent.
Biotech Stocks – This is a list of biotechnology companies. The list will include both penny stocks as well as more establish stocks. Biotech stocks are popular because of their big swings in price.
Tech Stocks – Technology stocks have become some of the most valued stocks in the world. On this page we like to focus on stocks that are still under the radar you will find a list of several different Tech Stocks.
Food Stocks– This page has a list of food and beverage stocks. You can click on the linked stocks at the bottom to get more information on each stock.
Penny Stocks List – This list include which stocks we have on our monthly watchlist. You will find a variety of different stocks here.
Solar Stocks – This is a list of solar energy stocks. Many believe clean energy is the future. This list give some of the hottest solar stocks.
New Gold (NGD) went up against a noteworthy extension venture by endorsing to assemble the Rainy River gold mine in Canada. This was a major wager, in light of the fact that if the gold price would have stayed at $1100/oz, the arrival on venture on the Rainy River task would have been appalling. Luckily, gold is presently exchanging above $1300/oz again and not just does this expansion the edges of Rainy River, it additionally permits New Gold to produce more money on its different properties to subsidize the progressing development exercises.
After somewhat over a year of investigating vital choices, Magellan Petroleum Corporation (NASDAQ: MPET) has reported arrangements to converge with a secretly held LNG organization called Tellurian Investments. The organizations are planning to finish the consolidation procedure before the end of this current year and the joined element is relied upon to go up against another name.
Magellan Petroleum Corporation, through its wholly owned subsidiary, Magellan Petroleum Australia Limited, and its 100% controlling interest in Nautilus Poplar LLC, is engaged in the sale of oil and gas and the exploration for and development of oil
Sonde Resources Corp as of late declared that it has recorded an intentional task in liquidation compliant with the arrangements of the Bankruptcy and Insolvency Act (Canada).
Since 2012, Sonde has been seeking after choices for the Joint Oil Block. Most as of late, in March of 2014, Sonde reported that it had drawn in Taylor-DeJongh, Inc. (“Taylor-DeJongh”) to start a procedure to investigate and assess potential vital other options to upgrade shareholder esteem with respect to the Joint Oil Block.
Sonde’s Management and Taylor-DeJongh have effectively sought after all prospects and alternatives accessible
Financial specialists of Sanchez Production Partners LP (SPP) are heading into second half of this current year trusting that the 6 month downtrend will switch itself. Over the past half year shares are down – 22.83% over that time span. All the more as of late the stock is 0.77% in the course of the last 5 exchanging days. Watching somewhat farther the stock is 0.48% for the month and 2.06% for the quarter.
Its outstanding shares are at 58,580,870, while authorized share are standing around 150,000,000.
At the session level, shares of Sanchez Production
Credit Suisse has started coverage of Synergy Resources Corp with an outperform rating and a value focus of $9, speaking to a potential upside of 53 percent versus the gathering at 26 percent upside.
Its outstanding shares are at 77,999,082, while authorized share are standing around 200,000,000.
After the organization’s obtaining of 33,100 net sections of land inside its center Greeley Crescent improvement territory from Noble Energy, Inc. In May of this current year, Synergy now assesses it has more than 1,000 gross longer horizontal boring areas in the Greeley Crescent advancement
Tengasco, Inc. (NYSEMKT: TGC) as of late declined to acknowledge a buyout offer that esteemed it at $0.2736 per share. The offer originated from a substance calling itself ICN Fund. The leading body of Tengasco took a gander at the offer and in the wake of assessing it deliberately, it turned the decision that it underestimated the organization.
Its outstanding shares are at 60,842,413, while authorized share are standing around 100,000,000.
The inquiry that rapidly strikes a chord at this crossroads is if Tengasco is not worth $0.2736 per share, what is it worth?
At the point when the shareholders of TransAtlantic Petroleum (NYSEMKT:TAT) accumulated for the yearly shareholder meeting, things looked really troubling. The loan specialists needed out and another managing an account relationship was distressfully required. Dropping oil costs were just exacerbating things. Furthermore one of Turkey’s neighbors is battling a common war.
Its outstanding shares are at 40,708,120, while authorized share are standing around 100,000,000.
The organization figured out how to acquire an advance, as expressed in the second quarter report, notwithstanding the fairly precarious circumstance in Turkey and its neighbors. While the term credit may not be
Zion Oil and Gas, Inc. (Zion Oil) is an underlying stage oil and gas investigation organization with oil and gas investigation in Israel. It holds two investigation licenses covering roughly 162,100 sections of land coastal in the State of Israel between Netanya in the south and Haifa in the north.
Its outstanding shares are at 36,400,000, while authorized share are standing around 200,000,000.
Zion Oil and Gas had a yearly essential combined EPS of $-0.1953 for the period finished 2015-12-31. For the quarter finished 2015-12-31 which was on quarterly premise, the fundamental
Pain Therapeutics is a Solid Pick in Biotech Industry
Pain Therapeutics is working in the biotech and pharmaceutical industry, having a business sector capitalization of $116.69 million. Opioid misuse is a developing pestilence, and the weight is on to grow better manhandle impediment definitions. Torment Therapeutics is creating two such items, one oral and the other a patch.
The present share price is $2.55, which places it in penny stock domain (under $5.00). In this manner, the dangers connected with penny stocks and low market capitalizations ought to be considered. Financial specialists who comprehend the dangers ought to consider this
Pieris Pharmaceuticals Inc. (PIRS:NASDAQ) was initially a German-based organization emerging from exploration done on some novel proteins. They framed in 2001, and have stretched into numerous sickness signs: oncology, iron deficiency, asthma, ophthalmology, and irresistible illness.
Coming from Technical University of Munich (TUM) through Dr. Arne Skerra’s work, Pieris was conceived. They are as of now transitioning into a move to be headquartered in the U.S. from Germany. We’ll go into this later, however we trust this is to stay away from rivalry in Europe.
With a business sector top of simply over $65 million USD,
Progenics (NASDAQ:PGNX) reported Q2 EPS and incomes in front of perspectives, and it was not because of superior to anything expected Relistor sovereignties. The organization perceived a $4 million point of reference installment from Bayer (OTCPK:BAYRY) for the PSMA Antibody Technology permit. This cooperation could open some shareholder esteem in the next years. News broke a week ago that Relistor is drawing some purchaser interest and that Valeant (NYSE:VRX) may offer its rights to the most noteworthy bidder.
A $400-500 million sticker price was specified in the Bloomberg article. The inferred cost allots little esteem to Relistor considering
ImmunoCellular (IMUC) has gained ground in the main portion of this current year, and the organization says that 2016 will be a year of achievement for its organization. The main patient in the ICT-107 stage 3 trial was dealt with in June – a noteworthy accomplishment for its organization. Today, more than 140 patients have been screened and clinical site enactment is quickening.
The organization presently have initiated 60 clinical destinations in the US, two in Canada, and one in the UK, with more anticipated that would come in the second from last quarter. With ICT-107, ImmunoCellular is
Meagerly exchanged nano cap Provectus Biopharmaceuticals (PVCT) droops on a 4x surge in volume in light of the evaluating of its “earnest attempts” public equity offering.
The organization is putting forth 240K shares of Series B Convertible Preferred Stock, at first convertible into a total of 24M shares of regular stock, and warrants to buy up to 24M shares of basic at a cost of $25 for a blend of one Series B offer and one quickly exercisable five-year warrant to buy one offer of basic at $0.275.
In the event that effective, gross proceeds will be
Skyline (NASDAQ:SKLN) recently reported \that it was expanding its unit trade offering. This offering from January permits financial specialists who acquired the more established, August 2015, units to trade those units for recently offered units.
In August, Skyline raised $19M by offering 1,666,667 units with every unit comprising of one offer of normal stock, one Series B convertible offer and four Series A warrants. The Series A warrants are exercisable at $4.95/share furthermore incorporated a “cashless” change highlight.
The more up to date units’ Series B warrants had generously comparative components to the old Series A warrants however
IMMUNOMEDICS, INC. (IMMU) got agreement suggestion of “Beat” from Analysts surveyed at Thomson Reuters. The Company anticipated that would declare next income roughly $-0.13 for each share.
One Month Ago Analyst Ratings: The Company has gotten mean Analyst rating of 2.00 from surveyed investigators at Reuters One Month Ago. It has been recommended as “Purchase Opinions” from 1 and 0 issued “Offer Thoughts” for the stock. 1 evaluated the organization as a “Hold”. “Beat View” rating was uncovered by 0 and “Fail to meet expectations Signal” rating was issued by 0.
On August 16, 2016, Aurinia’s share price had dove in spite of its Phase 2B study meeting the essential endpoints in the treatment of Lupus Nephritis with Aurinia’s lead drug voclosporin.
Analysts was entirely shocked by the negative response to Aurinia’s stock price after the discharge on August 15 of the exceptionally positive Phase 2B top line information from the twofold visually impaired 265 patient AURA investigation of voclosporin in the treatment of Lupus Nephritis (“LN”). The essential endpoints in the study were met, and analysts anticipated that the stock price would physically increment (not
Sucampo Pharmaceuticals (NASDAQ:SCMP) is a worldwide biopharmaceutical organization essentially centered around the innovative work (R&D) of medications. Its principle item, AMITIZA, is the main chloride channel activator produced for the treatment of endless blockage. It may not be the sexiest item, but rather the best medications once in a while are.
Since 2006, AMITIZA, otherwise called lubiprostone, has been administered more than 10 million times. As of now, it is accessible as a little oral gelcap taken twice per day and is endorsed for three signs that spread unmistakable patient sorts: unending idiopathic obstruction (CIC), fractious inside
Mast Therapeutics (NYSEMKT:MSTX) says stage 3 EPIC trial of vepoloxamer, which treats people with sickle cell illness encountering vaso-occlusive emergency, did not meet its essential adequacy endpoint.
Endpoint was measurably huge diminishment in the mean length of VOC (82 hours in the vepoloxamer bunch contrasted with 78 hours in the fake treatment bunch in the plan to-treat populace (p=0.09)). There were no measurably critical contrasts between treatment bunches in the goal to-treat populace over the two optional viability endpoints, rate of re-hospitalization for VOC and the event of intense mid-section disorder.
Marinus Pharmaceuticals, Inc. (MRNS ) was a major mover recently, as its shares ascended more than 29%. The move went ahead strong volume too with significantly a greater number of shares changing hands than in an ordinary session. Recent rally proceeds with the late uptrend for the organization, as the stock is currently up more than 55% in the previous one-month time period.
Marinus Pharmaceuticals has been on somewhat of an icy streak of late, however there may be promising end to present circumstances for this ignored stock. What’s more, for specialized financial specialists there is
MiMedx Group Inc (MDXG) shares exchanged higher after the organization reported strong growth in its second quarter and increased its full year guidance.
The organization said that in light of the quarter-to-date comes about, it sees income between $62 million and $64 million for the second from last quarter. Examiners gauge $63.12 million income. The organization communicated the certainty that the new item dispatches like OrthoFlo would empower it to accomplish the upper end of the income estimate.
For the entire year, MiMedx emphasized its direction of $243.5–$248 million with final quarter income to be exceptionally